Loss of Somatostatin Receptor Subtype 2 in Prostate Cancer Is Linked to an Aggressive Cancer Phenotype, High Tumor Cell Proliferation and Predicts Early Metastatic and Biochemical Relapse.

Saved in:

Bibliographic Details
Title:	Loss of Somatostatin Receptor Subtype 2 in Prostate Cancer Is Linked to an Aggressive Cancer Phenotype, High Tumor Cell Proliferation and Predicts Early Metastatic and Biochemical Relapse.
Authors:	Hennigs, Jan K.^1,2 j.hennigs@uke.de, Müller, Julia¹, Adam, Matti³, Spin, Joshua M.³, Riedel, Emilia¹, Graefen, Markus⁴, Bokemeyer, Carsten², Sauter, Guido¹, Huland, Hartwig⁴, Schlomm, Thorsten⁴, Minner, Sarah¹
Source:	PLoS ONE. Jul2014, Vol. 9 Issue 7, p1-10. 10p.
Database:	Academic Search Ultimate

Description
ISSN:	19326203
DOI:	10.1371/journal.pone.0100469